Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Glioblastoma (WHO-Grade IV Glioma)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00503204
What this trial is testing

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Who this might be right for
Recurrent GlioblastomaBrain Tumor
AstraZeneca 20
Not applicableLooking for participantsNCT05284643
What this trial is testing

Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
University of Miami 96
Testing effectiveness (Phase 2)Study completedNCT00611325
What this trial is testing

Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma

Who this might be right for
GlioblastomaGliosarcoma
Duke University 56
Testing effectiveness (Phase 2)Study completedNCT03027388
What this trial is testing

Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma

Who this might be right for
Astrocytoma, Grades II, III and IVGlioblastoma MultiformeGiant Cell Glioblastoma+2 more
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Study completedNCT03243851
What this trial is testing

Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma

Who this might be right for
Glioblastoma
Yong-Kil Hong 81
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06258018
What this trial is testing

Niraparib and Temozolomide in Patients Glioblastoma

Who this might be right for
Glioma, Malignant
Armando Santoro, MD 86
Testing effectiveness (Phase 2)Ended earlyNCT01966809
What this trial is testing

Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 1
Testing effectiveness (Phase 2)Study completedNCT01260506
What this trial is testing

Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Vascular Biogenics Ltd. operating as VBL Therapeutics 75
Testing effectiveness (Phase 2)UnknownNCT00054496
What this trial is testing

Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
The Cleveland Clinic 73
Testing effectiveness (Phase 2)Study completedNCT00615927
What this trial is testing

Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)

Who this might be right for
GlioblastomaGliosarcoma
Duke University 64
Testing effectiveness (Phase 2)UnknownNCT00009854
What this trial is testing

Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
Direct Therapeutics
Early research (Phase 1)Study completedNCT00003484
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Darell D. Bigner, MD, PhD 21
Early research (Phase 1)UnknownNCT02844062
What this trial is testing

Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Beijing Sanbo Brain Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00498927
What this trial is testing

Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center 47
Not applicableStudy completedNCT04974983
What this trial is testing

Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma

Who this might be right for
GlioblastomaAngiogenesis
University Hospital Regensburg 203
Testing effectiveness (Phase 2)Ended earlyNCT00243022
What this trial is testing

Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System TumorsCerebral Edema
Ali Altunkaya 12
Early research (Phase 1)Study completedNCT02101905
What this trial is testing

Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Oligodendroglioma+4 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Study completedNCT00238303
What this trial is testing

Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 103
Testing effectiveness (Phase 2)Study completedNCT02540161
What this trial is testing

Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma

Who this might be right for
Malignant Glioma
Annick Desjardins 43
Early research (Phase 1)Looking for participantsNCT07492316
What this trial is testing

RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)

Who this might be right for
Recurrent Medulloblastoma
University of Florida 24
Next Page